Publications by Meredith James - ePrints

Browsing publications by Meredith James.

Newcastle Authors	Title	Year
Catherine Turner Dr John Bourke Meredith James Jassi Sodhi Dr Marianela Schiava et al.	Development of respiratory care guidelines for Duchenne muscular dystrophy in the UK: key recommendations for clinical practice	2024
Dr Marianela Schiava Robert Muni Lofra Dr John Bourke Meredith James Professor Jordi Diaz Manera et al.	Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy	2024
Dr Marianela Schiava Dr John Bourke Meredith James Dr Maha Elseed Dr Monika Malinova et al.	Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids	2024
Dr Ursula Moore Dr Anna Mayhew Heather Hilsden Dr Hai The Pham Meredith James et al.	Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy	2024
Professor Michela Guglieri Laura Behar Dr Marianela Schiava Meredith James	Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years	2024
Meredith James Professor Michela Guglieri Dr Anna Mayhew	Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data	2024
Meredith James	266th ENMC International Workshop: Remote delivery of clinical care and validation of remote clinical outcome assessments in neuromuscular disorders: A response to COVID-19 and proactive planning for the future. Hoofddorp, The Netherlands, 1–3 April 2022	2023
Dr Ursula Moore Carla Bolaño Diaz Meredith James Professor Andrew Blamire Georgina Boyle et al.	Expanding the muscle imaging spectrum in dysferlinopathy: description of an outlier population from the classical MRI pattern	2023
Dr Ursula Moore Esther Fernández-Simón Dr Marianela Schiava Daniel Cox Meredith James et al.	Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy	2023
Meredith James Dr Michelle Eagle Robert Muni Lofra Dr ursula Moore Professor Michela Guglieri et al.	Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale	2022
Dr ursula Moore Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Lizzie Harris et al.	Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study	2022
Meredith James Dr Anna Mayhew Emerita Professor Katherine Bushby Professor Volker Straub	Comparison of strength testing modalities in dysferlinopathy	2022
Dr Fiona Smith Dr Ian Wilson Roberto Fernandez-Torron Meredith James Dr Ursula Moore et al.	Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy	2022
Meredith James Robert Muni Lofra Dionne Moat Mark Richardson Dr Michelle Eagle et al.	Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies	2022
Dr ursula Moore Dr Fiona Smith Dr Ian Wilson Meredith James Dr Anna Mayhew et al.	Water T2 could predict functional decline in patients with dysferlinopathy	2022
Meredith James	Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases	2021
Dr Ursula Moore Meredith James Dr Anna Mayhew Professor Michela Guglieri Roberto Fernandez-Torron et al.	Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease	2021
Meredith James Dr Michelle Eagle	Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic	2021
Dr Ursula Moore Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Professor Andrew Blamire et al.	Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With Dysferlinopathy	2020
Dr Alex Murphy Meredith James Dr Anna Mayhew Dr Michelle Eagle Dr Kieren Hollingsworth et al.	Natural history of limb girdle musclar dystrophy R9 over 6 years: searching for trial endpoints	2019
Dr Anna Mayhew Meredith James Professor Volker Straub	Performance of Upper Limb module for Duchenne muscular dystrophy	2019
Professor Jordi Diaz Manera Roberto Fernandez-Torron Meredith James Dr Anna Mayhew Dr Fiona Smith et al.	Muscle MRI in dysferlinopathy patients: Pattern recognition and implications for clinical trials	2018
Dr Ursula Moore Meredith James Dr Anna Mayhew Dr Fiona Smith Dr Lizzie Harris et al.	Clinical outcome study for dysferlinopathy: One-year follow-up	2016
Dr Lizzie Harris Dr Catherine Bladen Dr Anna Mayhew Meredith James Karen Bettinson et al.	The Clinical Outcome Study for dysferlinopathy: An international multicenter study	2016
Dr Cecilia Jimenez Moreno Dr Sira Moreno Dr Michelle Eagle Dr Anna Mayhew Meredith James et al.	Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy	2015
Dr Anna Mayhew Meredith James Dr Michelle Eagle Dr Catherine Bladen Karen Bettinson et al.	Preparation of a disease specific functional measure suitable for trials in dysferlinopathy	2015
Meredith James	Activity rating scales in adult muscle disease: How well do they actually measure?	2014
Dr Lizzie Harris Karen Bettinson Meredith James Dr Anna Mayhew Dr Michelle Eagle et al.	International Clinical Outcome Study in Dysferlinopathy (COS): Results of screening questionnaires in UK patients	2014
Dr Michelle Eagle Dr Anna Mayhew Karen Bettinson Meredith James Dr Brigitta von Rekowski et al.	Clinical outcome measures for dysferlinopathy: An exploration of reliability and suitability of novel functional rating scales	2013
Dr Anna Mayhew Dr Michelle Eagle Meredith James Emerita Professor Katherine Bushby	Performance of Upper Limb Scale for use in Duchenne muscular dystrophy - An iterative process to establish its suitability for clinical trials	2013
Meredith James Dr Michelle Eagle Dr Anna Mayhew	Clinical Evaluator training for the GSK DEMAND programme	2012